Literature DB >> 18058643

Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.

K Roessler1, B Gatterbauer, A Becherer, M Paul, K Kletter, D Prayer, R Hoeftberger, J Hainfellner, S Asenbaum, E Knosp.   

Abstract

OBJECTIVE: The objective of this study was to investigate the histological correlate of (11)C-methionine (MET) PET uptake of brain gliomas by image fusion for navigated surgery.
METHODS: Twenty-seven patients (18 male, 9 female; mean age 42 years; range 11-77 years; 8 low-grade and 11 high-grade astrocytomas or mixed gliomas, 8 oligodendrogliomas) underwent MET PET studies preoperatively.
RESULTS: MET PET tumor uptake was detected in 26 of 27 patients (96.3%). The quantitative MET tumor standardized uptake value (SUV) ratio was significantly higher in malignant gliomas and oligodendrogliomas than in low-grade gliomas (2.76/2.62 vs. 1.67, p=0.03). Generally, qualitative visual grading of MET uptake revealed 2 main patterns: focal MET uptake in 12 and uniform global MET uptake in 11 patients. Focal uptake corresponded to malignant glioma histology in 66.7%, and uniform global uptake to oligodendroglial histology in 72.7%. In oligodendrogliomas, global MET uptake constituted 81.5% (range 53.8-135%) of the MRI T(1) tumor volume on average and was limited to the MRI FLAIR tumor volume in 86% (7/8) of patients. Tissue samples of focal MET uptake areas correlated with histological anaplasia in 66.6% (8/12 glioma patients), although 62.5% (5/8 patients) lacked MRI contrast enhancement.
CONCLUSION: MET PET image fusion may facilitate the targeting of anaplastic foci in homogeneous MRI non-enhancing gliomas for biopsy, may identify oligodendroglial histology preoperatively as well as characterize biologically active tumor volumes within MRI T(1)/FLAIR tumor areas of candidate patients for resection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18058643     DOI: 10.1055/s-2007-991143

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  10 in total

1.  Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.

Authors:  Michail Plotkin; C Blechschmidt; G Auf; F Nyuyki; L Geworski; T Denecke; W Brenner; F Stockhammer
Journal:  Eur Radiol       Date:  2010-06-03       Impact factor: 5.315

2.  Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.

Authors:  Vera C Keil; Bogdan Pintea; Gerrit H Gielen; Susanne Greschus; Rolf Fimmers; Jürgen Gieseke; Matthias Simon; Hans H Schild; Dariusch R Hadizadeh
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

Review 3.  Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.

Authors:  A Brodbelt
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

4.  Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.

Authors:  Javier Arbizu; S Tejada; J M Marti-Climent; R Diez-Valle; E Prieto; G Quincoces; C Vigil; M A Idoate; J L Zubieta; I Peñuelas; J A Richter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-19       Impact factor: 9.236

5.  A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma.

Authors:  Ellen S Kim; Martin Satter; Marilyn Reed; Ronald Fadell; Arash Kardan
Journal:  Neuroradiol J       Date:  2016-04-27

6.  Atypical basal ganglia germinoma presenting as cerebral hemiatrophy: diagnosis and follow-up with 11C-methionine positron emission tomography.

Authors:  Jeehun Lee; Bo Lyun Lee; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo; Su Jin Lee; Joon Young Choi; Kyung-Han Lee; Jung Il Lee; Hyung-Jin Shin; Ji Hye Kim; Yeon Lim Suh; Ke Hyang Lee; Munhyang Lee
Journal:  Childs Nerv Syst       Date:  2008-08-19       Impact factor: 1.475

7.  5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.

Authors:  Georg Widhalm; Barbara Kiesel; Adelheid Woehrer; Tatjana Traub-Weidinger; Matthias Preusser; Christine Marosi; Daniela Prayer; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

8.  Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.

Authors:  Olivia Näslund; Anja Smits; Petter Förander; Mats Laesser; Jiri Bartek; Jens Gempt; Ann Liljegren; Eva-Lotte Daxberg; Asgeir Store Jakola
Journal:  Acta Neurochir (Wien)       Date:  2018-05-24       Impact factor: 2.216

9.  Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.

Authors:  Keisuke Miyake; Aya Shinomiya; Masaki Okada; Tetsuhiro Hatakeyama; Nobuyuki Kawai; Takashi Tamiya
Journal:  J Biomed Biotechnol       Date:  2012-04-11

10.  Using ADC Maps with Structural Scans to Improve Intraoperative Biopsy Specimens in Brain Metastases.

Authors:  Rasheed Zakaria; Michael D Jenkinson
Journal:  Neuroradiol J       Date:  2014-08-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.